Spotlight Innovation Inc. (fka STLT)

[Ecomike]

STLT technologies:

http://www.spotlightinnovation.com/biotechnologies/


Cancer
BIOTECHNOLOGY INDICATIONS MECHANISM OF ACTION
Crotoxin Solid cancers (melanoma, breast cancer and non-small cell lung cancer) Attacks cell membrane and triggers apoptosis (cell death). The compound also provides analgesic effects. Operates as a single product therapeutic.
Immunoplex™ • Breast cancer
• Melanoma
• Pancreatic cancer
• Non-small cell lung cancer Immune complexes are recognized by Antigen Presenting Cells (APCs) through antibody-specific receptors called Fc Receptors. The immune complexes stimulate APCs that then subsume the immune complexes. The APCs use the subsumed material to educate the adaptive arm of the immune response (T and B cells) to attack the disease-related antigens.

Read more about the Immunoplex immunotherapy biotechnology
Cancer Imaging
BIOTECHNOLOGY INDICATIONS MECHANISM OF ACTION
Crotamine
(Being developed in cooperation with Emory University) Cancer diagnostics (imaging, location, staging/metastasis, ?etc.) When administered, Crotamine naturally seeks out and enters malignant cells, signaling the location, size and status of the tumor.